(redirected from Biopolymers)
Also found in: Medical, Encyclopedia.


A macromolecule in a living organism that is formed by linking together several smaller molecules, as a protein from amino acids or DNA from nucleotides.


(Biology) a large molecule in a living organism


(ˌbaɪ oʊˈpɒl ə mər)

1. any polymeric chemical manufactured by a living organism, as a protein or polysaccharide.
2. such a chemical prepared by laboratory synthesis.
Mentioned in ?
References in periodicals archive ?
com/research/hvtqrv/renewable) has announced the addition of the "Renewable Chemicals Market - Alcohols (Ethanol, Methanol), Biopolymers (Starch Blends, Regenerated Cellulose, PBS, Bio-PET, PLA, PHA, Bio-PE, and Others), Platform Chemicals & Others - Global Trends & Forecast to 2020" report to their offering.
an advanced biomaterials company, entered into a global, exclusive commercial and technology alliance with Honeywell to offer new marine biodegradable biopolymers for use in cosmetics and personal care products.
Radiation from low levels of uranium in WA s Mulga Rock deposit changed the molecular arrangement of organic matter, which produced biopolymers not found in nature.
As a consequence, biopolymers are increasingly popular: According to figures published last year by European Bioplastics, global biopolymer production capacity increased from 250,000 tonnes in 2009 to almost 1.
Biopolymers are usually polymers produced naturally by living species, their molecular backbones composed of repeating units of saccharides, nucleic acids, or amino acids but they can also be built from monomers extracted from living species.
The purpose of the research is to review the information on the role of different biopolymers in the development of antimicrobial textiles," the research abstract reads.
8(th) annual Biopolymers Symposium will be held June 11-12, 2013 at Chicago's Field Museum
Chitin and chitosan are natural biopolymers, wherein chitin is readily found in nature and chitosan is a deacetylated chitin derivative.
Hallgreen R-8010 is a bio-based polymeric succinate that is said to improve the flexibility and pliability of biopolymers including polylactic acid (PLA), starch-based polymers, polyhydroxyalkanoate (PHA) and polyhydroxybutyrate (PHB), while maintaining long-term compatibility.
NatureWorks is embarking on a major capital investment project at its Blair, NE, USA, manufacturing facility for the production of new grades of high-performance Ingeo biopolymers as well as a new generation of lactide intermediates.
Compounders have blended biopolymers with conventional resins in order to add the "green" factor--renewably sourced content hopefully while making minimal change to the properties of the familiar petro-based plastic.
Marketing of the Solanyl biopolymers range from Rodenburg in the Netherlands has been taken on by IMCD Group, also based in the Netherlands, whose UK arm is the former Honeywill & Stein business in Sutton and Dublin.